Quantcast

Industry news that matters to you.  Learn more

Clusterin Not a Potential Early Biomarker for Alzheimer’s Disease Development

According to a recent study published in the Journal of the American Medical Association, plasma clusterin levels are significantly associated with prevalence and severity of Alzheimer’s disease (AD), but not with incidence.

Xention to Characterize Biomarkers for AF Consortium

Cambridge-based biopharmaceutical company Xention announced yesterday that it is a partner in the new multidisciplinary atrial fibrillation research consortium, the European Network for Translational Research in Atrial Fibrillation (EUTRAF). The consortium has been awarded a 12 million euro grant to engage in atrial fibrillation (AF) research.

Detection of Cardiac Biomarker Associated With Structural Heart Disease, Increased Risk of Death

With the use of a highly sensitive test, detection of the blood biomarker cardiac troponin T, a cardiac-specific protein, is associated with structural heart disease and an increased risk of all-cause death, according to a study in the December 8 issue of JAMA.

Pacific Biomarkers Poised to Join Battle Against Sharp Rise in Diabetes Cases Projected for the Year 2050 by Centers for Disease Control

Pacific Biomarkers, Inc., a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has responded to a recent report from the Centers for Disease Control projecting that as many as one in three adult Americans may suffer diabetes symptoms by the year 2050.

USC Studies Nitric Oxide’s Link to Asthma

Children with elevated levels of exhaled nitric oxide (FeNO) are at increased risk for developing asthma, particularly among children without a parental history of the disease, a study by researchers at the Keck School of Medicine of USC has found. The study is published in the European Respiratory Journal.